Core Outcome Set–STAndards for Reporting: The COS-STAR Statement
Paula Williamson and colleagues present reporting standards for studies that report core outcome sets for health research.
Vyšlo v časopise:
Core Outcome Set–STAndards for Reporting: The COS-STAR Statement. PLoS Med 13(10): e32767. doi:10.1371/journal.pmed.1002148
Kategorie:
Guidelines and Guidance
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1002148
Souhrn
Paula Williamson and colleagues present reporting standards for studies that report core outcome sets for health research.
Zdroje
1. Gorst SL, Gargon E, Clarke M, Blazeby JM, Altman DG, Williamson PR. Choosing Important Health Outcomes for Comparative Effectiveness Research: An Updated Review and User Survey. PLoS ONE. 2016; 11(1): e0146444. doi: 10.1371/journal.pone.0146444 26785121
2. Williamson PR, Altman DG, Blazeby JM, Clarke M, Devane D, Gargon E et al. Developing core outcome sets for clinical trials: issues to consider. Trials. 2012; 13:132. doi: 10.1186/1745-6215-13-132 22867278
3. COMET Initiative. 2016. http://www.comet-initiative.org/. [Accessed 5 May 2016].
4. Gargon E, Gurung B, Medley N, Altman DG, Blazeby JM, Clarke M et al. Choosing Important Health Outcomes for Comparative Effectiveness Research: A Systematic Review. PLoS ONE. 2014; 9(6): e99111. doi: 10.1371/journal.pone.0099111 24932522
5. Sinha I, Smyth RL, Williamson PR. Using the Delphi technique to determine which outcomes to measure in clinical trials: recommendations for the future based on a systematic review of existing studies. PLoS Med. 2011; 8(1): e1000393. doi: 10.1371/journal.pmed.1000393 21283604
6. Moher D, Schulz KF, Simera I, Altman DG. Guidance for developers of health research reporting guidelines. PloS Med. 2010; 7(2): e1000217. doi: 10.1371/journal.pmed.1000217 20169112
7. Clarke M and Williamson PR. Core outcome sets and systematic reviews. Systematic Reviews. 2016; 5:11. doi: 10.1186/s13643-016-0188-6 26792080
8. Kirkham JJ, Gorst S, Altman DG, Blazeby J, Clarke M, Devane D et al. COS-STAR: a reporting guideline for studies developing core outcome sets (protocol). Trials. 2015; 16:373. doi: 10.1186/s13063-015-0913-9 26297658
9. Schmitt J, Spuls PI, Thomas KS, Simpson E, Furue M, Deckert S et al. The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials. J Allergy Clin Immunol. 2014; 134:800–807. doi: 10.1016/j.jaci.2014.07.043 25282560
10. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ et al. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trial. BMJ. 2010; 340:c869. doi: 10.1136/bmj.c869 20332511
11. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis J et al. The PRISMA Statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and Elaboration. PLoS Med. 2009;6(7):e1000100. doi: 10.1371/journal.pmed.1000100 19621070
12. Schmitt J, Apfelbacher C, Spuls PI, Thomas KS, Simpson E, Furue M et al. The Harmonizing Outcome Measures for Eczema (HOME) roadmap: A methodological framework to develop core sets of outcome measurements in dermatology. Journal of Investigative Dermatology. 2015; 135 (1):24–30. doi: 10.1038/jid.2014.320 25186228
13. Smith MA, Leeder SR, Jalaludin B, Smith WT. The asthma health outcome indicators study. Australian and New Zealand Journal of Public Health. 1996; 20 (1): 69–75. doi: 10.1111/j.1467-842X.1996.tb01340.x 8799071
14. Sinha I, Gallagher R, Williamson PR, Smyth RL. Development of a core outcome set for clinical trials in childhood asthma: a survey of clinicians, parents, and young people. Trials. 2012; 13:103. doi: 10.1186/1745-6215-13-103 22747787
15. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009; 180(1):59–99. doi: 10.1164/rccm.200801-060ST 19535666
16. Busse WW, Morgan WJ, Taggart V, Togias A. Asthma outcomes workshop: overview. Journal of Allergy & Clinical Immunology. 2012; 129 (3) Suppl: S1–8. doi: 10.1016/j.jaci.2011.12.985
17. Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. PLoS Med. 2010;7(3): e1000251. doi: 10.1371/journal.pmed.1000251 20352064
18. Brookes S, Macefield R, Williamson P, McNair A, Potter S, Blencowe N et al. Three nested RCTs of dual or single stakeholder feedback within Delphi surveys during core outcome and information set development. Trials. 2015 Nov 16;16(Suppl 2):P51
19. Committee for Medicinal Products for Human Use (CHMP) (2015). Guideline on the clinical investigation of medicinal products for the treatment of asthma. CHMP/EWP/2922/01 Rev.1. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2015/12/WC500198877.pdf
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2016 Číslo 10
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- MUDr. Dana Vondráčková: Hepatopatie sú pri liečbe metamizolom väčším strašiakom ako agranulocytóza
- Vztah mezi statiny a rizikem vzniku nádorových onemocnění − metaanalýza
- Nech brouka žít… Ať žije astma!
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
Najčítanejšie v tomto čísle
- Prophylactic Oral Dextrose Gel for Newborn Babies at Risk of Neonatal Hypoglycaemia: A Randomised Controlled Dose-Finding Trial (the Pre-hPOD Study)
- Orthostatic Hypotension and the Long-Term Risk of Dementia: A Population-Based Study
- Improving the Science of Measles Prevention—Will It Make for a Better Immunization Program?
- Conveying Equipoise during Recruitment for Clinical Trials: Qualitative Synthesis of Clinicians’ Practices across Six Randomised Controlled Trials